Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20191217045765N1Phase 3Completed
Phase 3 trial of zinc in type 2 diabetes mellitus (T2DM) and end-stage kidney disease (ESKD), sponsored by Zahedan University of Medical Sciences. Started Dec 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20191217045765N1.